AFLD 2013 FFC vs Respondent M56

Facts
French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M56 for a violation of the Anti-Doping Rules. During the federal cyclo-cross championship on January 20, 2013, a sample was taken for a doping test. The sample highlighted the presence of prednisone and prednisolone. These substances are prohibited according the World Anti-Doping Agency (WADA) prohibited list and are regarded as specified substances.

History
The respondent claims that the positive test derives from his medication for bronchitis for which he has a medical certificate.

Decision
1. The respondent is acquitted.
2. The decision will be published and sent to the parties involved.

Original document

AFLD 2013-56 (S).pdf

Parameters

Legal Source
National Decisions
Date
30 May 2013
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acquittal
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Cyclisme (FFC) - French Cycling Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S9. Glucocorticosteroids
Substances
Prednisolone
Prednisone
Medical terms
Legitimate Medical Treatment
Therapeutic Use Exemption (TUE)
Document type
Pdf file
Date generated
27 January 2014
Date of last modification
25 September 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin